Advanced search
Publication Cover
Journal of Dietary Supplements Volume 17, 2020 - Issue 4
Submit an article Journal homepage
387
Views
15
CrossRef citations to date
0
Altmetric
Reviews

The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis

Fariborz Mansour-GhanaeiGI Cancer Screening and Prevention Research Center, Guilan University of Medical Sciences, Rasht, Iran; ;Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; Correspondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-9197-0787
, MDORCID Icon,
Makan PourmasoumiGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; ;Caspian Digestive Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; ORCID Iconhttp://orcid.org/0000-0001-9335-7276
, MScORCID Icon,
Amir HadiHalal Research Center of IRI, FDA, Tehran, Iran; ;Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran; ORCID Iconhttp://orcid.org/0000-0001-9952-6579
, MScORCID Icon,
Nahid Ramezani-JolfaieDepartment of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
, PhD &
Farahnaz JoukarGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; ;Caspian Digestive Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; Correspondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0001-8432-8879
, PhDORCID Icon
Pages 467-485 | Published online: 01 Jul 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, Christos Kiosses & Jannis Kountouras. (2020) Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents. Expert Opinion on Pharmacotherapy 21:3, pages 247-251.
Read now

Articles from other publishers (14)

Triada Bali, Lampros Chrysavgis & Evangelos Cholongitas. (2023) Metabolic-Associated Fatty Liver Disease and Sarcopenia. Endocrinology and Metabolism Clinics of North America 52:3, pages 497-508.
Crossref
Federico Carbone, Luca Liberale, Peter Libby & Fabrizio Montecucco. (2023) Vitamin D in atherosclerosis and cardiovascular events. European Heart Journal 44:23, pages 2078-2094.
Crossref
Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon & Sang Geon Kim. (2023) Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences 24:8, pages 7454.
Crossref
Ammar Salehi‐Sahlabadi, Hamed Kord‐Varkaneh, Betul Kocaadam‐Bozkurt, Shaikh Sanjid Seraj, Seyed Moayed Alavian & Azita Hekmatdoost. (2022) Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial. Phytotherapy Research 36:11, pages 4201-4209.
Crossref
Pouya Rostamizadeh, Seyed Mohammad Kazem Hosseini Asl, Zohreh Ghaem Far, Pegah Ahmadijoo, Trias Mahmudiono, Dmitry Olegovich Bokov, Fahad Alsaikhan, Behrooz Jannat & Zohreh Mazloom. (2022) Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double‐blind clinical trial. Phytotherapy Research 36:10, pages 3949-3956.
Crossref
Ilias D. Vachliotis, Athanasios D. Anastasilakis, Antonis Goulas, Dimitrios G. Goulis & Stergios A. Polyzos. (2022) Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. Diabetes, Obesity and Metabolism 24:9, pages 1702-1720.
Crossref
Zahra Rahimpour, Rastegar Hoseini & Nasser Behpour. (2022) Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease. BMC Gastroenterology 22:1.
Crossref
Yoko M. Ambrosini, Cesar Piedra‐Mora, Sam Jennings & Cynthia R. L. Webster. (2022) Serum 25‐hydroxyvitamin D and C‐reactive protein and plasma von Willebrand concentrations in 23 dogs with chronic hepatopathies. Journal of Veterinary Internal Medicine 36:3, pages 966-975.
Crossref
Bassem Refaat, Abdelghany H. Abdelghany, Jawwad Ahmad, Osama M. Abdalla, Gehad E. Elshopakey, Shakir Idris & Mohamed El‐Boshy. (2021) Vitamin D 3 enhances the effects of omega‐3 oils against metabolic dysfunction‐associated fatty liver disease in rat . BioFactors 48:2, pages 498-513.
Crossref
Hamid Yaghooti, Fatemeh Ghanavati, Seyed Saeed Seyedian, Bahman Cheraghian & Narges Mohammadtaghvaei. (2021) The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism. BMC Pharmacology and Toxicology 22:1.
Crossref
D. A. Teplyuk, M. Ch. Semenistaya, S. M. Sorokoletov, L. B. Lazebnik & Ch. S. Pavlov. (2021) Nonalcoholic liver disease: review with a focus on risks of progression. Experimental and Clinical Gastroenterology:8, pages 167-174.
Crossref
Milica Bjelakovic, Dimitrinka Nikolova, Goran Bjelakovic & Christian Gluud. (2021) Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2021:10.
Crossref
Xiaowei He, Cheng Xu, Zheng-Hong Lu, Xiao-Zheng Fang, Juan Tan & Yingjian Song. (2020) Low serum 25-hydroxyvitamin D levels are associated with liver injury markers in the US adult population. Public Health Nutrition 23:16, pages 2915-2922.
Crossref
Yilan Zeng, Mei Luo, Liwei Pan, Yuan Chen, Siqi Guo, Dongxia Luo, Li Zhu, Yong Liu, Lisha Pan, Siya Xu, Ruofei Zhang, Chunyan Zhang, Pengfei Wu, Liangpeng Ge, Mazen Noureddin, Stephen J. Pandol & Yuan-Ping Han. (2020) Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. American Journal of Physiology-Gastrointestinal and Liver Physiology 318:3, pages G542-G553.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.